ESMO-Preceptorship-Lung-Cancer-2024-1000x250-November

Start date: 15 Nov 2024
End date: 16 Nov 2024
Location: Paris, France
Application deadline: Closed

Learning objectives

To learn about best clinical practice in the management of NSCLC in early, locally advanced, and metastatic stages
To learn about the management of patients with actionable driver alterations and novel targeted agents for advanced NSCLC
To understand the role of immune checkpoint blockade for lung cancer and to learn about novel immunotherapies
To learn about the systemic treatment of mesothelioma, SCLC and thymoma

Download the preliminary programme

Co-Chairs

Solange Peters, Switzerland
David Planchard, France

How to apply

Application is via online form. During the application process you will be required to upload the following:

Your CV including a list of your publications
3-5 slides presenting a clinical case (please use the ESMO Preceptorship Case Presentation Power Point template, provided here)

Application deadline

Application for the course is now closed.

Who can apply?

While this course is primarily aimed at oncologists resident in Europe, application is open to all ESMO members.

To apply, ESMO membership is mandatory. If you are not an ESMO member or need to renew your membership, please visit the ESMO membership pages.

What's included?

Successful applicants will benefit from complimentary course registration and accommodation.

Travel grant

In addition to the course registration and the hotel accommodation, a travel grant of maximum 600 euros is offered to non-local participants as a contribution versus their travel costs (excluding Visa costs).

Participants must supply proof of travel as appropriate (tickets and receipts/invoices).

The reimbursement will be processed after the course according to the rules below:

Distance from the city of departure* to the city of arrival**	Reimbursement per return trip
Up to 100 km	EUR 70.00
101 > 399 km	EUR 150.00
> 400 km	Please visit this page and use the rail or flight calculator by inserting the city of departure and the city of arrival; then refer to Table 2 (on the same page) to check the reimbursement amount corresponding to the calculated distance.
Place of work *Course venue

Accreditation

The programme of this event has been accredited with 12 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.

Health and Safety Policy

It is each participant’s responsibility to check and comply with the latest health and travel regulations to ensure a smooth and safe journey from the Country of origin to the event venue, and back.

During the event, ESMO will apply health and safety protocols according to the latest local authority guidelines and regulations.

In general, ESMO recommends:

to apply health precautions and measures according to formal guidance and personal medical history
to stay up to date with the vaccination status
to perform a Rapid Antigen Test and wear a mask in case of symptoms

Hand sanitisers will be available throughout the venue; the use of mask is at own discretion in the absence of symptoms.

Any changes to the ESMO health and safety protocols will be communicated on this webpage.

Insurance

ESMO bears no responsibility for any untoward events in connection with, before, during and after the course. Participants are strongly advised to take out their own personal and travel coverage.

Venue

Mercure Paris Porte de Versailles Expo
36 38 Rue du Moulin,
92170 Vanves, France